Envisagenics is a bioinformatics startup developing cloud-based solutions to leverage biomedical big data and accelerate R&D therapeutics through machine learning. Envisagenics is a spin-off from Cold Spring Harbor Laboratory, a biomedical research institute ranked #1 worldwide for scientific impact in the field of genetics. Envisagenics’ core technology, SpliceCore® was developed by our CTO while at Cold Spring Harbor Laboratory in Dr. Adrian Krainer’s Laboratory, a leader in the RNA splicing field. The mission of Envisagenics is to materially advance the world’s ability to cure diseases, discovering new and more efficient drug targets through the analysis and integration of genomic data alongside our pharma partners.
Envisagenics evaluates qualified applicants without regard to race, color, national origin, religion, sex, sexual orientation, gender identity, disability, protected veteran status, and other statuses protected by law.